24/7MN – Clovis Oncology Inc. (NASDAQ: CLVS) Continues to Squeeze Higher and may be preparing to challenge 200 DMA

Clovis Oncology Inc. (NASDAQ: CLVS)

(24/7 MARKET NEWS) Clovis Oncology Inc. (NASDAQ: CLVS) remains one of the most heavily shorted stocks, with a reported 29.08% short interest ratio and 4.4 days to cover. We’ve covered Clovis, since early in this move and, despite the daily moving averages being out of whack, really like the set up and wave pattern. We hope that it doesn’t spike too much

It’s up $0.4072 (+22.62%), at $2.2072, on 8,589,379 shares, and it looks like it may have a go at its 200 day simple moving average resistance that’s just above $2.50.

We hope that it doesn’t spike too much and outrun its support, but, if it does, the meme traders and momo players could turbo charge its moves from there.

24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.

Please go to www.247marketnews.com or https://www.247marketnews.com/terms-disclaimer/ for further information.


Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.


Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist